Generate Biomedicines

Lead Investors

ARCH Venture Partners, Abu Dhabi Investment Authority, Alaska Permanent Fund, Altitude Life Science Ventures, Amgen, Fidelity Investments, Flagship Pioneering, MAPS Capital, March Capital, Mirae Asset Global Investments, Morningside Venture Partners, NVentures, Pictet Group, and T. Rowe Price

대륙

US

법인설립년도

2018

산업

Biotechnology

서비스 소개

Generative biology platform intended to invent new drugs across protein modalities and protein therapeutics

순번

44

지역

Cambridge, MA

최근 투자규모(달러환율 적용)

$273M

최종 투자규모(달러환율적용)

$643M

투자 단계

Series C